The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Apolipoprotein E: Structure-Function Relationships
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We identified Gly145Asp and Arg154Cys in the same J o u r n a l P r e -p r o o f region (amino acids ~ 148 to 168) [47]”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [47]
In the citing paper
“Variants predicted by models to be deleterious or being located near or in the receptor binding region (amino acids ~ 148 to 168) [47] could be suspected to pose ε2-like qualities.”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [47]
In the citing paper
“Additional support comes from the present data, where Gly145Asp and Arg154Cys are located in the receptor binding region (amino acids ≈148 to 168) 28 and display a phenotype similar to the ɛ2‐defining Arg176Cys residue with high apoE levels and seemingly low risk of dementia (no events).”
From APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) · cites this paper as [28]
In the citing paper
“Val254Glu and Arg269Gly are located in the lipid‐binding carboxyl‐terminal domain (amino acids ≈243 to 317). 28 , 42”
From APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) · cites this paper as [28]
In the citing paper
“However, the receptor-binding sites (AA136-150) for lipoprotein receptors such as the low-density lipoprotein receptor (LDLR), lipoprotein-related receptor 1 (LRP1), and heparan sulfate proteoglycans (HSPGs) are located in a region conserved between species (Fig. 1a) [11–14].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“Notably, an HSPG and LDLR binding site in the APOE sequence is conserved in mice (blue boxed area, AA136-150), including arginine 136, which is replaced by serine in the Christchurch (Ch) variant [12, 39].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“However, mAPOE and hAPOE have a conserved LDLR and HSPG binding motif between AA136 to 150 (human numbering) [11, 12, 39], which includes the R136S Christchurch variant.”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“The mature apoE protein consists of 299 amino acids and an 18amino acid signal peptide is removed post-translationally [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“The APOE gene is located on chromosome 19 and consists of four exons [28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“Lipid-free apoE consists of two domains connected by a “hinge region”: the amino-terminal domain (amino acids 1 to 191) contains the receptor-binding function and the carboxyl-terminal domain (~amino acids 225 to 299) contains the lipid-binding function [28,33].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“The low density lipoprotein (LDL) receptor binding region is situated in helix four between amino acids 136 and 150 [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“ApoE2 exhibits a lower affinity to the LDL receptor compared to apoE3: ~1% of the binding activity of apoE3 and apoE4 [28,36].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“Furthermore, apoE and apoB share the sequence with highest affinity for arterial proteoglycans, a key phenomenon for lipoprotein deposition in the arterial wall [28,63].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“ApoE contains two independently folded functional domains; these are a 22-kDa N-terminal domain (residues 1–191) and a 10-kDa C-terminal domain (residues 216–299) linked by a hinge region (18, 19).”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [18]
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Prediction of protein conformation
Chou, P. Y., & Fasman, G. D. (1974) · Biochemistry · doi:10.1021/bi00699a002 · Cited by 3,309
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Research works printed but not linked: 17
- Cassel, 1984, Atherosclerosis (Shannon, Irel.), 52, 203
- Hallman, 1991, Am. J. Hum. Genet., 49, 338
- Havel, 1989, 1, 1129
- Koizumi, 1985, Antherosclerosis (Shannon, Irel.), 58, 175
- Landis, 1987, Am. J. Physiol., 252, G805
- Lund-Katz, 1993, J. Biol. Chem.
- Mahley, 1983, Arch. Pathol. Lab. Med., 107, 393
- Mahley, 1989, 1, 1195
- Mahley, 1983, 4, 151
- Mahley, 1977, Am. J. Pathol., 87, 205
- Mahley, 1983, Biochim. Biophys. Acta., 737, 197, 10.1016/0304-4157(83)90001-1 · DOI
- Mahley, 1989, 1, 1195
- Phillips, 1986, 128, 387
- Srinivasan, 1972, Atherosclerosis (Shannon, Irel.), 16, 95
- Utermann, 1980, Am. J. Hum. Genet., 32, 339
- Weisgraber, 1983, 4, 103
- Yamamura, 1984, Atherosclerosis (Shannon, Irel.), 50, 159
Cited by
Sorted by citations
Items 601–700 of 828
Hossain, M. M., Adhikari, J., Dutta, A., Khandaker, A., Islam, S., Rahman, M. M., & Shibly, A. Z. (2025) · PLOS One · doi:10.1371/journal.pone.0331339 · Cited by 11
Shabbir, R., Malik, M. N. H., Zaib, M., Alamgeer, Jahan, S., & Khan, M. T. (2022) · ACS Omega · doi:10.1021/acsomega.2c05735 · Cited by 11
Vezeridis, A. M., Drosatos, K., & Zannis, V. I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m008409 · Cited by 11
Berg, M. J., Durrie, R., Sapirstein, V. S., & Marks, N. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01445-x · Cited by 11
Apolipoprotein E Modulates Establishment of HSV-1 Latency and Survival in a Mouse Ocular Model
Bhattacharjee, P. S., Neumann, D. M., Stark, D. T., Thompson, H. W., & Hill, J. M. (2006) · Current Eye Research · doi:10.1080/02713680600864600 · Cited by 11
Sequence of horse (Equus caballus) apoA-II. Another example of a dimer forming apolipoprotein
Puppione, D. L., Fischer, W. H., Park, M.-K., Whitelegge, J. P., Schumaker, V. N., Golfeiz, S., & MacDonald, M. H. (2004) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpc.2004.02.008 · Cited by 11
Dong, J., Balestra, M. E., Newhouse, Y. M., & Weisgraber, K. H. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31971-4 · Cited by 11
Self-citationInnate immune responses to HIV infection in the central nervous system
Geffin, R., & McCarthy, M. (2013) · Immunologic Research · doi:10.1007/s12026-013-8445-4 · Cited by 10
Age-Dependent Expression of Apolipoprotein E in Mouse Cerebral Cortex
Singh, S., & Thakur, M. K. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9412-3 · Cited by 10
Kuot, A., Ronci, M., Mills, R. A., Klebe, S., Snibson, G. R., Wiffen, S. J., Loh, R. S. K., Corbett, M. A., Zhou, T., Chataway, T., et al. (2019) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13569 · Cited by 10
Oh, J., Nam, Y., Jo, A., Cheon, H., Rhee, S., Park, J., Lee, J., & Kim, H. K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06773.x · Cited by 10
Cerebrospinal Fluid Apolipoprotein E, Calcium and Cerebral Vasospasm after Subarachnoid Hemorrhage
Alexander, S. A., Kerr, M. E., Balzer, J. R., Horowitz, M., Kassam, A. B., Kim, Y., Hoffman, L. A., & Conley, Y. P. (2008) · Biological Research For Nursing · doi:10.1177/1099800408321722 · Cited by 10
Gordon, S. E., & Perugini, M. A. (2016) · Springer eBooks · doi:10.1007/978-4-431-55985-6_16 · Cited by 10
Lee, D., Kim, K.-M., Kim, B.-T., Kim, K.-N., & Joo, N. (2011) · Yonsei medical journal · doi:10.3349/ymj.2011.52.3.429 · Cited by 8
Demacker, P. N. M., Bredie, S. J. H., Vogelaar, J. M., Hectors, M. P. C., van Heijst, P. J., Stuyt, P. M. J., & Stalenhoef, A. F. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00035-5 · Cited by 10
Marancik, D. P., Perrault, J. R., Komoroske, L. M., Stoll, J. A., Kelley, K. N., & Manire, C. A. (2021) · Conservation Physiology · doi:10.1093/conphys/coab018 · Cited by 9
Alternative lipid mobilization: The insect shuttle system
HORST, D. J. V. D., Hoof, D. V., Marrewijk, W. J. A. V., & Rodenburg, K. W. (2002) · Springer eBooks · doi:10.1007/978-1-4419-9270-3_15 · Cited by 10
Djan, I., Stokić, E., Sakač, D., Djan, M., Obreht, D., Erak, M., & Jovanovic, N. (2011) · Archives of Biological Sciences · doi:10.2298/abs1101089d · Cited by 9
A Biophysical Approach to the Identification of Novel ApoE Chemical Probes
Kraft, L., Serpell, L. C., & Atack, J. R. (2019) · Biomolecules · doi:10.3390/biom9020048 · Cited by 9
Apolipoprotein E binds to and reduces serum levels of DNA-mimicking, pyrrolated proteins
Hirose, S., Hioki, Y., Miyashita, H., Hirade, N., Yoshitake, J., Shibata, T., Kikuchi, R., Matsushita, T., Chikazawa, M., Itakura, M., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006629 · Cited by 9
Liu, G., Chen, L., Tian, H., Sun, G., Wei, F., Meng, Y., & Ma, R. (2023) · Metabolites · doi:10.3390/metabo13030396 · Cited by 9
Dergunov, A. D., Visvikis‐Siest, S., & Siest, G. (2008) · Vascular Pharmacology · doi:10.1016/j.vph.2007.12.001 · Cited by 9
Dijck-Brouwer, D. A. J., van Doormaal, J. J., Kema, I. P., Brugman, A. M., Kingma, A. W., & Muskiet, F. A. J. (2005) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/0004563054255498 · Cited by 9
[10] Quantitation of apolipoprotein E
Krul, E. S., & Cole, T. G. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)63012-2 · Cited by 9
Induction of cytokine tolerance requires internalization of Chylomicron-Bound LPS into hepatocytes
Kasravi, F. B., Brecht, W. J., Weisgraber, K. H., & Harris, H. W. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00197-5 · Cited by 9
Self-citationNMR evidence for a conformational adaptation of apolipophorin III upon lipid association
Wang, J., Sahoo, D., Sykes, B. D., & Ryan, R. O. (1998) · Biochemistry and Cell Biology · doi:10.1139/bcb-76-2-3-276 · Cited by 9
Association of human apolipoprotein E with lipoproteins secreted by transfected McA RH7777 cells
Reardon, C. A., Blachowicz, L., Watson, K. M., Barr, E., & Getz, G. S. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32517-7 · Cited by 9
Feussner, G., Albanese, M., & Valencia, A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05870-4 · Cited by 7
Amukti, D. P., Wazni, A. R., Irham, L. M., Sulistyani, N., Ma’ruf, M. F., Adikusuma, W., Sarasmita, M. A., Khairi, S., Purwanto, B. D., Suyatmi, S., et al. (2024) · E3S Web of Conferences · doi:10.1051/e3sconf/202450101021 · Cited by 8
Interactions between TTYH2 and APOE facilitate endosomal lipid transfer
Sukalskaia, A., Karner, A., Pugnetti, A., Weber, F., Plochberger, B., & Dutzler, R. (2025) · Nature · doi:10.1038/s41586-025-09200-x · Cited by 10
Lipid-bound ApoE3 self-assemble into elliptical disc-shaped particles
Larsen, A. H., Johansen, N. T., Gajhede, M., Arleth, L., & Midtgaard, S. R. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183495 · Cited by 8
Multidimensional NMR studies of an exchangeable apolipoprotein and its interactions with lipids
Wang, J., Sahoo, D., Schieve, D., Gagné, S. M., Sykes, B. D., & Ryan, R. O. (1997) · Techniques in protein chemistry · doi:10.1016/s1080-8914(97)80043-9 · Cited by 8
Chen, J., & Wang, J. (2011) · Journal of Biomolecular NMR · doi:10.1007/s10858-011-9526-0 · Cited by 8
Morishima‐Kawashima, M., Han, X., Tanimura, Y., Hamanaka, H., Kobayashi, M., Sakurai, T., Yokoyama, M., Wada, K., Nukina, N., Fujita, S. C., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04400.x · Cited by 8
Replacement of helix 1′ enhances the lipid binding activity of apoE3 N‐terminal domain
Redmond, K. A., Murphy, C., Narayanaswami, V., Kiss, R. S., Hauser, P. S., Guigard, E., Kay, C. M., & Ryan, R. O. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05089.x · Cited by 9
Koivisto, A. M. (2006) · Cited by 8
Riddell, D. R., & Owen, J. S. (1996) · Thrombosis Research · doi:10.1016/0049-3848(96)87301-4 · Cited by 8
Anatomy by computer experiment of the exchange of a water molecule buried in human apolipoprotein E
Prévost, M. (1998) · Folding and Design · doi:10.1016/s1359-0278(98)00049-2 · Cited by 8
Apolipoprotein E: Emerging Story in the Pathogenesis of Alzheimer's Disease
Strittmatter, W. J., & Roses, A. D. (1995) · The Neuroscientist · doi:10.1177/107385849500100507 · Cited by 8
Calabuig-Navarro, V., Jackson, K. G., Kemp, C. F., Leake, D. S., Walden, C. M., Lovegrove, J. A., & Minihane, A. M. (2017) · Scientific Reports · doi:10.1038/srep44119 · Cited by 8
Conformational Reorganization of Apolipoprotein E Triggered by Phospholipid Assembly
Prakashchand, D. D., & Mondal, J. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c03011 · Cited by 7
Aguilar-Pineda, J. A., Paco-Coralla, S. G., Febres-Molina, C., Gamero-Begazo, P. L., Shrivastava, P., Vera-López, K. J., Dávila-Del-Carpio, G., López-Casaperalta, P., Gómez, B., & Cardenas, C. L. L. (2022) · Biomolecules · doi:10.3390/biom12040499 · Cited by 7
Frisardi, V. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111568 · Cited by 7
Luckhoff, H. K., Kidd, M., van Rensburg, S. J., van Velden, D. P., & Kotze, M. J. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9737-2 · Cited by 7
Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis
Rafiei, M., Yeganeh, M. Z., Sheikholeslami, S., Gozalpour, E., Ghaffarpour, M., & Hedayati, M. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.050 · Cited by 7
Chen, X., Liang, H., Soliman, M. L., & Geiger, J. D. (2014) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000002 · Cited by 7
Yang, L., Hernandez, R. V., Tran, T. N., Nirudodhi, S. N., Beck, W. H. J., Maier, C. S., & Narayanaswami, V. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.08.005 · Cited by 7
Galeazzi, L., Corder, E. H., Galeazzi, R., Casoli, T., Valli, M. B., & Giunta, S. (2002) · Amyloid · doi:10.3109/13506120208995242 · Cited by 7
Oda, M. N., & Ryan, R. O. (2007) · Wiley eBooks · doi:10.1002/9783527625178.ch1 · Cited by 7
Apolipoprotein-mimetic Peptides: Current and Future Prospectives
Pande, A. H., Nankar, S. A., Ahmed, S., & Sharma, S. S. (2022) · Current Protein and Peptide Science · doi:10.2174/1389203723666221003122624 · Cited by 6
Biological Markers in Nursing Research
Alexander, S. A., Kalmakis, K. A., Fahs, P. S., Groth, S. W., & Chasens, E. R. (2017) · Journal of Nursing Measurement · doi:10.1891/1061-3749.25.2.275 · Cited by 6
Abeer, M. I., Abdulhasan, A., Haguar, Z., & Narayanaswami, V. (2023) · FEBS Journal · doi:10.1111/febs.16729 · Cited by 6
Zaib, M., Malik, M. N. H., Shabbir, R., Mushtaq, M. N., Younis, W., Jahan, S., Ahmed, I. M., & Kharl, H. A. A. (2023) · ACS Omega · doi:10.1021/acsomega.3c00443 · Cited by 6
Molecular dynamics simulation of apolipoprotein E3 lipid nanodiscs
Allen, P., Smith, A. C., Benedicto, V., Abdulhasan, A., Narayanaswami, V., & Tapavicza, E. (2023) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2023.184230 · Cited by 6
Sakuma, N., Hibino, T., Saeki, T., Nagata, T., Sato, T., Okuda, N., Matsunaga, A., & Sasaki, J. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.21394 · Cited by 6
Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
van Amersfoort, E. S., & Kuiper, J. (2007) · CRC Press eBooks · doi:10.3109/9781420020595-21 · Cited by 6
Role of leucine zipper motif in apoE3 N-terminal domain lipid binding activity
Yamamoto, T., & Ryan, R. O. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.07.006 · Cited by 7
Hauser, P. S., Raussens, V., Yamamoto, T., Abdullahi, G. E., Weers, P. M. M., Sykes, B. D., & Ryan, R. O. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800554-jlr200 · Cited by 6
Fisher, C. A., Kiss, R. S., Francis, G. A., Gao, P., & Ryan, R. O. (1999) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s0305-0491(99)00028-0 · Cited by 6
Apolipoproteins in circulation: At the interface of thrombosis and stroke initiation
Etuzé, T., Vivien, D., & Dubois, F. (2025) · Progress in Lipid Research · doi:10.1016/j.plipres.2025.101343 · Cited by 6
Generation of novel anti‐apo E monoclonal antibodies that selectively recognize apo E isoforms
Ohgita, T., Sakai, K., Fukui, N., Namba, N., Nakano, M., Kiguchi, Y., Morita, I., Oyama, H., Yamaki, K., Nagao, K., et al. (2024) · FEBS Letters · doi:10.1002/1873-3468.14858 · Cited by 5
Membranmimetische Nanotransporter auf Grundlage eines dipalmitoylierten zellpenetrierenden Peptids
Keller, S., Sauer, I., Strauss, H. M., Gast, K., Dathe, M., & Bienert, M. (2005) · Angewandte Chemie · doi:10.1002/ange.200500519 · Cited by 5
Connections between apolipoprotein E genotypes and the development of cardiovascular diseases
Végh, C., Langmár, Z., Szerző, M., Ágota, A., Marosi, K., Szabolcs, Z., & Nagy, Z. B. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29508 · Cited by 5
Molecular Mechanisms of the R61T Mutation in Apolipoprotein E4: A Dynamic Rescue
Williams, B., Convertino, M., Das, J., & Dokholyan, N. V. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.08.026 · Cited by 5
Apolipoprotein E Mimetic Peptides: Cholesterol-Dependent and Cholesterol-Independent Properties
Garber, D. W., Goldberg, D., & Anantharamaiah, G. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-17350-4_10 · Cited by 5
APOE ɛ4 Allele Frequency in Alzheimer's Disease and Vascular Dementia in the Spanish Populationa
Beyer, K., Lao, J. I., Fernández‐Novoa, L., Alvarez, X. A., SELLERS, M. A., & Cacabelos, R. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48502.x · Cited by 5
Capillary electrophoretic analysis of recombinant human apolipoprotein E
Schlenck, A., Schiele, F., Barbier, A., Shuvaev, V. V., Visvikis‐Siest, S., & Siest, G. (1999) · Journal of Chromatography A · doi:10.1016/s0021-9673(99)00520-8 · Cited by 5
Differential metabolism of apolipoprotein E isoproteins
Reardon, C. A. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.129067 · Cited by 5
Benedicto, V., Haguar, Z., Abdulhasan, A., & Narayanaswami, V. (2024) · ACS Omega · doi:10.1021/acsomega.3c09120 · Cited by 4
Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies
Tripathi, S., Sharma, Y., & Kumar, D. (2024) · Current Protein and Peptide Science · doi:10.2174/0113892037326839241014054430 · Cited by 5
Fotakis, P., Vezeridis, A., Dafnis, I., Chroni, A., Kardassis, D., & Zannis, V. I. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m048348 · Cited by 4
Conformational analysis of apolipoprotein E3/E4 heteromerization
Tu, K., Abhari, D., & Narayanaswami, V. (2019) · The FEBS Journal · doi:10.1111/febs.14794 · Cited by 4
Zhang, D., Gao, B., Feng, Q., Manichaikul, A. W., Peloso, G. M., Tracy, R. P., Durda, P., Taylor, K. D., Liu, Y., Johnson, W. C., et al. (2024) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2024.100383 · Cited by 3
Prévost, M., & Ortmans, I. (2001) · The Journal of Physical Chemistry B · doi:10.1021/jp003347x · Cited by 4
The Impact of Apolipoprotein E Allelic Variants on Alzheimer’s Disease
Serrano, E., Sanz, P. G., & Barrantes, F. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_29 · Cited by 4
Presenilinas, Apo E y enfermedad de Alzheimer
Pérez, N. P., Menéndez, S., & Rodríguez, J. J. L. (2002) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
Ortmans, I., & Prévost, M. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp8002678 · Cited by 4
Rył, A., Jasiewicz, A., Grzywacz, A., Adler, G., Skonieczna‐Żydecka, K., Rotter, I., Sipak‐Szmigiel, O., Rumianowski, B., Karakiewicz, B., Jurczak, A., et al. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13060543 · Cited by 4
Genetics of Alzheimer´S Disease
Campos‐Peña, V., Gmez, R., & Antônio, M. (2014) · InTech eBooks · doi:10.5772/58286 · Cited by 5
Human Apolipoprotein E concentration in response to diseases and therapeutic treatments
Siest, G., Zaiou, M., & Visvikis‐Siest, S. (2002) · Drug Development Research · doi:10.1002/ddr.10065 · Cited by 5
Prévost, M., & Kocher, J. (1999) · Protein Engineering Design and Selection · doi:10.1093/protein/12.6.475 · Cited by 4
McCarthy, M. M., Hardy, M. J., Leising, S. E., LaFollette, A. M., Stewart, E. S., Cogan, A. S., Sanghal, T., Matteo, K., Reeck, J. C., Oxford, J. T., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271707 · Cited by 4
Apolipoprotein E Recognizes Alzheimer's Disease Associated 3‐O Sulfation of Heparan Sulfate
Mah, D., Zhu, Y., Su, G., Zhao, J., Canning, A., Gibson, J. M., Song, X., Stancanelli, E., Xu, Y., Zhang, F., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202212636 · Cited by 3
Natural Plant Materials as a Source of Neuroprotective Peptides
Skibska, A., & Perlikowska, R. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230703145043 · Cited by 3
Polyanina, D. D., Bereza, I. A., Amromina, A. M., Shaikhova, D. R., Astakhova, S. G., Sutunkova, M. P., & Gurvich, V. B. (2023) · Health Risk Analysis · doi:10.21668/health.risk/2023.2.15 · Cited by 3
Formation of N.EPSILON.-(Hexanonyl)lysine in Oxidized Human Very-low-density Lipoprotein.
Arai, H., Kato, Y., Fukunaga, K., Mohri, S., & Nakamura, K. (2004) · SEIBUTSU BUTSURI KAGAKU · doi:10.2198/sbk.48.37 · Cited by 3
Su, K., Wen, T., Chou, C., Chang, G., Liu, G., & Hung, H. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21443 · Cited by 3
Goldstein, L. B., Vitek, M. P., Dawson, H. N., & Bullman, S. L. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00234-7 · Cited by 3
Hirofumi, A. R. A. I., Uchida, K., Fukunaga, K., Nagasaka, Y., Mohri, S., Furumoto, H., KURAMITSU, Y., & Nakamura, K. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.402 · Cited by 3
Cardiovascular DiseaseMouse Models of Atherosclerosis
MAEDA, N., CGIVENS, R., & LReddick, R. (2007) · Elsevier eBooks · doi:10.1016/b978-012369454-6/50070-4 · Cited by 3
Influence of the Apoe Genoptype on Serum Apoe Levels in Alzheimer’s Disease Patients
Corzo, L., Fernández‐Novoa, L., Zas, R., Beyer, K., Lao, J. I., Alvarez, X. A., & Cacabelos, R. (1998) · Advances in behavioral biology · doi:10.1007/978-1-4615-5337-3_109 · Cited by 3
Hazarika, L., Sen, S., Zawar, A., & Doshi, J. (2021) · Journal of Drug Design and Medicinal Chemistry · doi:10.11648/j.jddmc.20210702.11 · Cited by 3
Apolipoproteins in Different Amyloidoses
Sadowski, M., & Wısnıewskı, T. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_6 · Cited by 3
Oxidative Modification of Apolipoprotein E3 and Its Biological Significance
Hara, S., Tanaka, T., Yamada, M., Nagasaka, Y., & Nakamura, K. (1998) · Springer eBooks · doi:10.1007/978-4-431-68476-3_77 · Cited by 3
APOE p.(Leu167del) variant in hypercholesterolemia: Prevalence & phenotypic expression
Bello-Álvarez, D., Cenarro, A., Bea, A. M., Marco-Benedí, V., Jarauta, E., Ortiz-Palma, P., Ortega, E., González-Lleó, A. M., & Civeira, F. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.09.016 · Cited by 2
Novel method for reducing plasma cholesterol: a ligand replacement therapy
Anantharamaiah, G. M., & Goldberg, D. (2015) · Clinical Lipidology · doi:10.2217/clp.14.63 · Cited by 2
Haddad, J. F., Yang, Y., Yeung, S., & Couture, J. (2017) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2017.06.017 · Cited by 2
Fagla, B. M., York, J. M., Christensen, A., Rosa, C. D., Balu, D., Pike, C. J., Tai, L. M., & Buhimschi, I. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-66489-w · Cited by 2
Arai, H., & Nakamura, K. (2004) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.50.66 · Cited by 2
ApoE4 trapping by the low density lipoprotein receptor
Altenburg, M. K., Malloy, S. I., Knouff, C., Parks, J. S., & Maeda, N. (2004) · International Congress Series · doi:10.1016/j.ics.2003.11.035 · Cited by 2
Metadata
- Authors
- Weisgraber, K. H.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Weisgraber, Karl H.
- Venue
- Advances in Protein Chemistry
- Publisher
- Elsevier
- Published
- 1994
- Volume
- 45
- Pages
- 249-302
- ISSN
- 0065-3233 (ISSN-L)
- OpenAlex
- W98152484
- Cited by
- 830
- References
- 194
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 14 · 2023: 17 · 2022: 12 · 2021: 20 · 2020: 12 · 2019: 13 · 2018: 14 · 2017: 20 · 2016: 18 · 2015: 15 · 2014: 18 · 2013: 23 · 2012: 26
- FWCI
- 89.45
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in protein chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-41633, P01HL041633)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- apolipoprotein E, lipoprotein metabolism, apolipoprotein structure, APOE isoforms, lipid transfer proteins, lipoprotein receptors, triglyceride-rich lipoproteins, reverse cholesterol transport, lipolysis, serum lipoproteins
- MeSH terms
- Amino Acid Sequence, Animals, Apolipoproteins E, Humans, Molecular Sequence Data, Protein Conformation, Structure-Activity Relationship, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
